The antiparkinson agent pramipexole dihydrochloride monohydrate was quantified in pharmaceutical products by high performance liquid chromatography (HPLC) and derivative spectrophotometry. The first ...

The full CMI on the next page has more details. If you are worried about taking this medicine, speak to your doctor or pharmacist. Sifrol ER contains the active ingredient pramipexole dihydrochloride ...

Parkinson's disease is one of the most common neurodegenerative diseases worldwide. Swallowing difficulties present a significant challenge in the treatment of Parkinson's disease patients. Our ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Non-Commercial (NC): Only non-commercial uses of the work are permitted. No ...

As the COVID-19 pandemic continues to spread, new and unusual chronic sequelae of the disease are cropping up in many medical practices. Now, a new case paper published in The Lancet in September 2020 ...

A novel stability-indicating high-performance liquid chromatographic assay method was developed and validated for quantitative determination of pramipexole dihydrochloride in bulk drugs and in ...

This article explores what this transition to newer technology looks like, with an example applied to determining organic impurities of pramipexole dihydrochloride. The US Pharmacopeia (USP) provides ...

Mirapex is indicated to treat Parkinson’s disease (PD) symptoms and restless legs syndrome (RLS). Mirapex ER® is a dopamine agonist used to treat Parkinson's disease and restless legs syndrome (RLS).

1 Department of Neurology, National Center for Children's Health, Beijing Children's Hospital, Capital Medical University, Beijing, China 2 Department of Gastroenterology, National Center for Children ...